Market Analysis: Global Progenitor Cell-Based Market

Global progenitor cell-based market is estimated to register a substantial CAGR in the forecast period of 2019 to 2026. The imminent market report contains data for historic year 2017, the base year of calculation is 2018 and the forecast period is 2019 to 2026. The growth of the market can be attributed to the rising geriatric population.

Key Market Competitors:

Some of the major companies functioning in global progenitor cell-based market are F. Hoffmann-La Roche Ltd, Pfizer Inc., Merck & Co., Inc., Abbott, Vericel, Novartis AG, Alcon, GlaxoSmithKline plc, BAXTER INTERNATIONAL INC, Boehringer Ingelheim International GmbH, Amgen Inc., Bristol-Myers Squibb Company, Nuvasive, Inc., Organogenesis, Inc., Nu-Tech International,  MiMedx, Stability Biologic., Takara Bio Inc., Caladrius, Biosciences, Inc., U.S. Stem Cell, Inc., Cesca Therapeutics and Osiris Therapeutics, Inc among others

Get Sample Analysis of Global Market Information: https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-progenitor-cell-based-market

Market Definition: Global Progenitor Cell-Based Market

Progenitor cell are the kind of stem cell which are located in bone marrow and also called as hematopoietic. These cells give rise to the different cell lines. The progenitor cells can divide and stem cells can replicate indefinitely. Progenitor cells are used in various neurological disorders such as Parkinson disease and Huntington disease.

Prevalence of Parkinson’s disease (PD) increases with increasing age but an estimated four percent of people with Parkinson’s disease are diagnosed before age 50, more than 10 million people worldwide are living with Parkinson’s disease, and other neurological diseases.

Market Drivers

Rising of advanced genome-cell based techniques is driving the growth of the market
Investment in research and development activities along with government funding in   regenerative medicine will propel the market growth
Increasing number of clinical trials based on cell-based therapy is also fueling the market to grow in the forecast period
Development in cell banking infrastructure is boosting the market growth

Market Restraints

Unclear regulatory guidelines for product development is hampering the growth of the market
Less  availability of skilled professional may also hinder the market in the forecast period
Ethical concern in animal trial can hamper the market growth
Segmentation: Global Progenitor Cell-Based Market

By Type

Allogeneic Stem Cell
Musculoskeletal Disorders
Wounds and Injuries
Surgeries
Acute Graft-Versus-Host Disease (AGVHD)
Others
Autologous
Wounds and Injuries
Cardiovascular Diseases
Gastrointestinal Diseases
Others

By Therapeutic Application

Musculoskeletal Disorders
Wound and Injuries
Neurology
Cardiovascular Diseases (CVD)
Gastrointestinal Diseases
Surgeries
Others

By Cell Source

Adipose Tissue-Derived Mesenchymal Stem Cells
Bone Marrow-Derived Mesenchymal Stem Cells
By Embryo/Cord Blood Stem Cells
Others

By End User

Laboratory
Hospitals
Research Institute

By Geography

North America
U.S.
Canada
Mexico
South America
Brazil
Rest of South America
Europe
Germany
Italy
U.K.
France
Spain
Netherlands
Belgium
Switzerland
Turkey
Russia
Rest of Europe
Asia-Pacific
Japan
China
India
South Korea
Indonesia
Malaysia
Australia
Singapore
Thailand
Philippines
Rest of Asia-Pacific
Middle East and Africa
South Africa
Rest of Middle East & Africa

Get TOC of Full Report: https://www.databridgemarketresearch.com/toc/?dbmr=global-progenitor-cell-based-market

Key Developments in the Market:

In April 2019, Boehringer Ingelheim International GmbH, announced the launch of Arti Cell, a first ever registered stem cell-based veterinary medicine. This is ground breaking approved therapy which will use to reduce mild to moderate recurrent lameness related with non-septic joint inflammation in horses. With this launch, the company will enhance its product portfolio in the market
In January 2019, Japan government organization approved stem-cell treatment for spinal-cord injuries. This stem cell treatment is used to contract muscles and sense touch of the body. This approval will provide direction to the new era of healthcare and will create unprecedented revolution of science and medicine